Does breast-feeding affect severity of familial Mediterranean fever?

Balahan Makay1, Erbil Unsal

  • 1Department of Pediatrics, Division of Immunology-Rheumatology, Dokuz Eylul University Hospital, 35340 Balçova, Izmir, Turkey. balahan.bora@deu.edu.tr

Clinical Rheumatology
|August 19, 2009
PubMed

Insights

Breast-feeding duration does not impact Familial Mediterranean fever (FMF) severity. However, the M694V genotype is associated with more severe FMF disease phenotypes.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • Familial Mediterranean fever (FMF) is a common inherited autoinflammatory disorder affecting the innate immune system.
  • Environmental factors, such as microbial exposure, may influence FMF disease severity.
  • Breast-feeding is crucial for infant immunity and protection against infections.

Purpose of the Study:

  • To investigate the impact of breast-feeding and its duration on the disease severity of FMF.
  • To explore potential environmental influences on FMF phenotype.

Main Methods:

  • A questionnaire assessed infant feeding practices, mode of delivery, gestational age, and age of FMF symptom onset in 81 FMF patients.
  • Disease severity was scored using the Pras et al. system.
  • MEFV mutations were recorded.

Main Results:

  • Most FMF patients were breast-fed; however, breast-feeding duration did not correlate with disease severity.
  • Introducing cow's milk or complementary foods and longer breast-feeding did not delay symptom onset.
  • Homozygosity for the M694V mutation was linked to higher FMF severity scores.

Conclusions:

  • Breast-feeding does not appear to be an external factor influencing FMF phenotype.
  • The M694V genotype is a significant factor contributing to increased FMF disease severity.

Related Concept Videos

Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in response to an infection or illness.
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...